1.
Bellone M, Pradelli L, Tavarozzi R, Ladetto M, Nepoti G, Guardalben E, et al. Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis. FE [Internet]. 2022 Nov. 7 [cited 2025 Jul. 23];23(1). Available from: https://provafe.seedstm.com/index.php/FE/article/view/1532